Hotline: +86-18022463983    020-85206863

China AT1 Receptor Antagonists Market Report & Forecast 2021-2027

Published Date: 2021-10-08   |   Pages: 91   |   Tables: 106   |  Pharma & Healthcare

This report contains market size and forecasts of AT1 Receptor Antagonists in China, including the following market information:

China AT1 Receptor Antagonists Market Revenue, 2016-2021, 2022-2027, ($ millions)

China AT1 Receptor Antagonists Market Sales, 2016-2021, 2022-2027, (K Units)

China top five AT1 Receptor Antagonists companies in 2020 (%)

The global AT1 Receptor Antagonists market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.

The China AT1 Receptor Antagonists market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the AT1 Receptor Antagonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China AT1 Receptor Antagonists Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

China AT1 Receptor Antagonists Market Segment Percentages, By Type, 2020 (%)

Valsartan

Telmisartan

Losartan

Irbesartan

Azilsartan

Olmesartan

China AT1 Receptor Antagonists Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

China AT1 Receptor Antagonists Market Segment Percentages, By Application, 2020 (%)

Hypertension

Cardiovascular Diseases

Kidney Diseases

Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies AT1 Receptor Antagonists revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies AT1 Receptor Antagonists revenues share in China market, 2020 (%)

Key companies AT1 Receptor Antagonists sales in China market, 2016-2021 (Estimated), (K Units)

Key companies AT1 Receptor Antagonists sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer

Novartis

Merck

Astra Zeneca

Jhonson and Johnson

Eli Lilly

Sanofi

Bristol-Myers Squibb

Bayer

GSK

Teva Pharmaceutical

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Introduction to Research & Analysis Reports

1.1 AT1 Receptor Antagonists Market Definition

1.2 Market Segments

1.2.1 Segment by Type

1.2.2 Segment by Application

1.3 China AT1 Receptor Antagonists Market Overview

1.4 Methodology & Sources of Information

1.4.1 Research Methodology

1.4.2 Research Process

1.4.3 Base Year

2 China AT1 Receptor Antagonists Overall Market Size

2.1 China AT1 Receptor Antagonists Market Size: 2021 VS 2027

2.2 China AT1 Receptor Antagonists Revenue, Prospects & Forecasts: 2016-2027

2.3 China AT1 Receptor Antagonists Sales: 2016-2027

3 Company Landscape

3.1 Top AT1 Receptor Antagonists Players in China Market

3.2 Top China AT1 Receptor Antagonists Companies Ranked by Revenue

3.3 China AT1 Receptor Antagonists Revenue by Companies

3.4 China AT1 Receptor Antagonists Sales by Companies

3.5 China AT1 Receptor Antagonists Price by Manufacturer (2016-2021)

3.6 Top 3 and Top 5 AT1 Receptor Antagonists Companies in China Market, by Revenue in 2020

3.7 Manufacturers AT1 Receptor Antagonists Product Type

3.8 Tier 1, Tier 2 and Tier 3 AT1 Receptor Antagonists Players in China Market

3.8.1 List of Tier 1 AT1 Receptor Antagonists Companies in China

3.8.2 List of Tier 2 and Tier 3 AT1 Receptor Antagonists Companies in China

4 Sights by Type

4.1 Overview

4.1.1 By Type - China AT1 Receptor Antagonists Market Size Markets, 2021 & 2027

4.1.2 Valsartan

4.1.3 Telmisartan

4.1.4 Losartan

4.1.5 Irbesartan

4.1.6 Azilsartan

4.1.7 Olmesartan

4.2 By Type - China AT1 Receptor Antagonists Revenue & Forecasts

4.2.1 By Type - China AT1 Receptor Antagonists Revenue, 2016-2021

4.2.2 By Type - China AT1 Receptor Antagonists Revenue, 2022-2027

4.2.3 By Type - China AT1 Receptor Antagonists Revenue Market Share, 2016-2027

4.3 By Type - China AT1 Receptor Antagonists Sales & Forecasts

4.3.1 By Type - China AT1 Receptor Antagonists Sales, 2016-2021

4.3.2 By Type - China AT1 Receptor Antagonists Sales, 2022-2027

4.3.3 By Type - China AT1 Receptor Antagonists Sales Market Share, 2016-2027

4.4 By Type - China AT1 Receptor Antagonists Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

5.1 Overview

5.1.1 By Application - China AT1 Receptor Antagonists Market Size, 2021 & 2027

5.1.2 Hypertension

5.1.3 Cardiovascular Diseases

5.1.4 Kidney Diseases

5.1.5 Other

5.2 By Application - China AT1 Receptor Antagonists Revenue & Forecasts

5.2.1 By Application - China AT1 Receptor Antagonists Revenue, 2016-2021

5.2.2 By Application - China AT1 Receptor Antagonists Revenue, 2022-2027

5.2.3 By Application - China AT1 Receptor Antagonists Revenue Market Share, 2016-2027

5.3 By Application - China AT1 Receptor Antagonists Sales & Forecasts

5.3.1 By Application - China AT1 Receptor Antagonists Sales, 2016-2021

5.3.2 By Application - China AT1 Receptor Antagonists Sales, 2022-2027

5.3.3 By Application - China AT1 Receptor Antagonists Sales Market Share, 2016-2027

5.4 By Application - China AT1 Receptor Antagonists Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Overview

6.1.3 Pfizer AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.1.4 Pfizer AT1 Receptor Antagonists Product Description

6.1.5 Pfizer Recent Developments

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Overview

6.2.3 Novartis AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.2.4 Novartis AT1 Receptor Antagonists Product Description

6.2.5 Novartis Recent Developments

6.3 Merck

6.3.1 Merck Corporation Information

6.3.2 Merck Overview

6.3.3 Merck AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.3.4 Merck AT1 Receptor Antagonists Product Description

6.3.5 Merck Recent Developments

6.4 Astra Zeneca

6.4.1 Astra Zeneca Corporation Information

6.4.2 Astra Zeneca Overview

6.4.3 Astra Zeneca AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.4.4 Astra Zeneca AT1 Receptor Antagonists Product Description

6.4.5 Astra Zeneca Recent Developments

6.5 Jhonson and Johnson

6.5.1 Jhonson and Johnson Corporation Information

6.5.2 Jhonson and Johnson Overview

6.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.5.4 Jhonson and Johnson AT1 Receptor Antagonists Product Description

6.5.5 Jhonson and Johnson Recent Developments

6.6 Eli Lilly

6.6.1 Eli Lilly Corporation Information

6.6.2 Eli Lilly Overview

6.6.3 Eli Lilly AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.6.4 Eli Lilly AT1 Receptor Antagonists Product Description

6.6.5 Eli Lilly Recent Developments

6.7 Sanofi

6.7.1 Sanofi Corporation Information

6.7.2 Sanofi Overview

6.7.3 Sanofi AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.7.4 Sanofi AT1 Receptor Antagonists Product Description

6.7.5 Sanofi Recent Developments

6.8 Bristol-Myers Squibb

6.8.1 Bristol-Myers Squibb Corporation Information

6.8.2 Bristol-Myers Squibb Overview

6.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.8.4 Bristol-Myers Squibb AT1 Receptor Antagonists Product Description

6.8.5 Bristol-Myers Squibb Recent Developments

6.9 Bayer

6.9.1 Bayer Corporation Information

6.9.2 Bayer Overview

6.9.3 Bayer AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.9.4 Bayer AT1 Receptor Antagonists Product Description

6.9.5 Bayer Recent Developments

6.10 GSK

6.10.1 GSK Corporation Information

6.10.2 GSK Overview

6.10.3 GSK AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.10.4 GSK AT1 Receptor Antagonists Product Description

6.10.5 GSK Recent Developments

6.11 Teva Pharmaceutical

6.11.1 Teva Pharmaceutical Corporation Information

6.11.2 Teva Pharmaceutical Overview

6.11.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales and Revenue in China Market (2016-2021)

6.11.4 Teva Pharmaceutical AT1 Receptor Antagonists Product Description

6.11.5 Teva Pharmaceutical Recent Developments

7 China AT1 Receptor Antagonists Production Capacity, Analysis

7.1 China AT1 Receptor Antagonists Production Capacity, 2016-2027

7.2 AT1 Receptor Antagonists Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

8.1 Market Opportunities & Trends

8.2 Market Drivers

8.3 Market Restraints

9 AT1 Receptor Antagonists Supply Chain Analysis

9.1 AT1 Receptor Antagonists Industry Value Chain

9.2 AT1 Receptor Antagonists Upstream Market

9.3 AT1 Receptor Antagonists Downstream and Clients

9.4 Marketing Channels Analysis

9.4.1 Marketing Channels

9.4.2 AT1 Receptor Antagonists Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

11.1 Note

11.2 Examples of Clients

11.3 Author Details

11.4 Disclaimer

List of Tables

Table 1. Key Players of AT1 Receptor Antagonists in China Market

Table 2. Top AT1 Receptor Antagonists Players in China Market, Ranking by Revenue (2019)

Table 3. China AT1 Receptor Antagonists Revenue by Companies, (US$, Mn), 2016-2021

Table 4. China AT1 Receptor Antagonists Revenue Share by Companies, 2016-2021

Table 5. China AT1 Receptor Antagonists Sales by Companies, (K Units), 2016-2021

Table 6. China AT1 Receptor Antagonists Sales Share by Companies, 2016-2021

Table 7. Key Manufacturers AT1 Receptor Antagonists Price (2016-2021) & (USD/Unit)

Table 8. Manufacturers AT1 Receptor Antagonists Product Type

Table 9. List of Tier 1 AT1 Receptor Antagonists Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Tier 2 and Tier 3 AT1 Receptor Antagonists Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. Major Manufacturers of Valsartan

Table 12. Major Manufacturers of Telmisartan

Table 13. By Type – China AT1 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2027

Table 14. By Type - China AT1 Receptor Antagonists Revenue (US$, Mn), 2016-2021

Table 15. By Type - China AT1 Receptor Antagonists Revenue (US$, Mn), 2022-2027

Table 16. By Type - China AT1 Receptor Antagonists Sales (K Units), 2016-2021

Table 17. By Type - China AT1 Receptor Antagonists Sales (K Units), 2022-2027

Table 18. By Application – China AT1 Receptor Antagonists Revenue, (US$, Mn), 2021 VS 2027

Table 19. By Application - China AT1 Receptor Antagonists Revenue (US$, Mn), 2016-2021

Table 20. By Application - China AT1 Receptor Antagonists Revenue (US$, Mn), 2022-2027

Table 21. By Application - China AT1 Receptor Antagonists Sales (K Units), 2016-2021

Table 22. By Application - China AT1 Receptor Antagonists Sales (K Units), 2022-2027

Table 23. Pfizer Corporation Information

Table 24. Pfizer Description and Major Businesses

Table 25. Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 26. Pfizer AT1 Receptor Antagonists Product

Table 27. Pfizer Recent Developments

Table 28. Novartis Corporation Information

Table 29. Novartis Description and Major Businesses

Table 30. Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 31. Novartis AT1 Receptor Antagonists Product

Table 32. Novartis Recent Developments

Table 33. Merck Corporation Information

Table 34. Merck Description and Major Businesses

Table 35. Merck AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 36. Merck AT1 Receptor Antagonists Product

Table 37. Merck Recent Developments

Table 38. Astra Zeneca Corporation Information

Table 39. Astra Zeneca Description and Major Businesses

Table 40. Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 41. Astra Zeneca AT1 Receptor Antagonists Product

Table 42. Astra Zeneca Recent Developments

Table 43. Jhonson and Johnson Corporation Information

Table 44. Jhonson and Johnson Description and Major Businesses

Table 45. Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 46. Jhonson and Johnson AT1 Receptor Antagonists Product

Table 47. Jhonson and Johnson Recent Developments

Table 48. Eli Lilly Corporation Information

Table 49. Eli Lilly Description and Major Businesses

Table 50. Eli Lilly AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 51. Eli Lilly AT1 Receptor Antagonists Product

Table 52. Eli Lilly Recent Developments

Table 53. Sanofi Corporation Information

Table 54. Sanofi Description and Major Businesses

Table 55. Sanofi AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 56. Sanofi AT1 Receptor Antagonists Product

Table 57. Sanofi Recent Developments

Table 58. Bristol-Myers Squibb Corporation Information

Table 59. Bristol-Myers Squibb Description and Major Businesses

Table 60. Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 61. Bristol-Myers Squibb AT1 Receptor Antagonists Product

Table 62. Bristol-Myers Squibb Recent Developments

Table 63. Bayer Corporation Information

Table 64. Bayer Description and Major Businesses

Table 65. Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 66. Bayer AT1 Receptor Antagonists Product

Table 67. Bayer Recent Developments

Table 68. GSK Corporation Information

Table 69. GSK Description and Major Businesses

Table 70. GSK AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 71. GSK AT1 Receptor Antagonists Product

Table 72. GSK Recent Developments

Table 73. Teva Pharmaceutical Corporation Information

Table 74. Teva Pharmaceutical Description and Major Businesses

Table 75. Teva Pharmaceutical AT1 Receptor Antagonists Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 76. Teva Pharmaceutical AT1 Receptor Antagonists Product

Table 77. Teva Pharmaceutical Recent Developments

Table 78. AT1 Receptor Antagonists Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)

Table 79. China AT1 Receptor Antagonists Capacity Market Share of Key Manufacturers, 2019-2021

Table 80. AT1 Receptor Antagonists Market Opportunities & Trends in China Market

Table 81. AT1 Receptor Antagonists Market Drivers in China Market

Table 82. AT1 Receptor Antagonists Market Restraints in China Market

Table 83. AT1 Receptor Antagonists Raw Materials

Table 84. AT1 Receptor Antagonists Raw Materials Suppliers in China Market

Table 85. Typical AT1 Receptor Antagonists Downstream

Table 86. AT1 Receptor Antagonists Downstream Clients in China Market

Table 87. AT1 Receptor Antagonists Distributors and Sales Agents in China Market

List of Figures

Figure 1. AT1 Receptor Antagonists Product Picture

Figure 2. AT1 Receptor Antagonists Segment by Type

Figure 3. AT1 Receptor Antagonists Segment by Application

Figure 4. China AT1 Receptor Antagonists Market Overview: 2020

Figure 5. China AT1 Receptor Antagonists Market Size: 2021 VS 2027 (US$, Mn)

Figure 6. China AT1 Receptor Antagonists Revenue, 2016-2027 (US$, Mn)

Figure 7. AT1 Receptor Antagonists Sales in China Market: 2016-2027 (K Units)

Figure 8. The Top 3 and 5 Players Market Share by AT1 Receptor Antagonists Revenue in 2020

Figure 9. Valsartan Product Picture

Figure 10. Telmisartan Product Picture

Figure 11. Losartan Product Picture

Figure 12. Irbesartan Product Picture

Figure 13. Azilsartan Product Picture

Figure 14. By Type - China AT1 Receptor Antagonists Sales Market Share, 2016-2027

Figure 15. By Type - China AT1 Receptor Antagonists Revenue Market Share, 2016-2027

Figure 16. By Type - China AT1 Receptor Antagonists Price (USD/Unit), 2016-2027

Figure 17. Hypertension

Figure 18. Cardiovascular Diseases

Figure 19. Kidney Diseases

Figure 20. Other

Figure 21. By Application - China AT1 Receptor Antagonists Sales Market Share, 2016-2027

Figure 22. By Application - China AT1 Receptor Antagonists Revenue Market Share, 2016-2027

Figure 23. By Application - China AT1 Receptor Antagonists Price (USD/Unit), 2016-2027

Figure 24. Pfizer AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 25. Novartis AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 26. Merck AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 27. Astra Zeneca AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 28. Jhonson and Johnson AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 29. Eli Lilly AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 30. Sanofi AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 31. Bristol-Myers Squibb AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 32. Bayer AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 33. GSK AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 34. Teva Pharmaceutical AT1 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 35. China AT1 Receptor Antagonists Production Capacity (K Units), 2016-2027

Figure 36. AT1 Receptor Antagonists Industry Value Chain

Figure 37. Marketing Channels

Our Clients